Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The emphasis on the share charge may be misdirected. The true significance lies in the quality and return potential of the business Willowglen intends to acquire. While financing arrangements of this nature are typical and transient, the inherent value of the asset is what ultimately determines shareholder returns. Should Elixir II generate robust and consistent cash flow, this transaction would be considered value-enhancing, irrespective of any temporary encumbrance.
This structure isn't a weakness, it's a smart, capital-efficient move. The share charge is a normal way to finance things, and it doesn't take away Willowglen's profits from Elixir II. Instead of worrying about temporary issues, shareholders should look at whether the asset itself makes more money than it costs to finance. If it does, this deal boosts long-term value without diluting shares or draining cash.
I am curious about the strategic acquisitions being considered for Willow's future growth. Is Willow exploring enhancements in automation, advancements in software and AI, or strengthening our cybersecurity infrastructure? Alternatively, are there entirely different strategic directions we should consider?
Haha, don't be so greedy, lah. Don't put all your eggs in one basket, but also don't put all your eggs in too many baskets. Sometimes you win here, lose there. It's better to focus on one thing for a long time.
But being friends with the Malaysia gov is important too, you see, Itmax can go up to RM4++, and nobody cares what certifications or high-end skills you have, haha.
